Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era

955 indexed citations

Abstract

loading...

About

This paper, published in 2005, received 955 indexed citations. Written by Bengt Nilsson, Per Bümming, Jeanne M. Meis‐Kindblom, Anders Odén, Bengt Gustavsson and Lars‐Gunnar Kindblom covering the research area of Gastroenterology, Pulmonary and Respiratory Medicine and Surgery. It is primarily cited by scholars working on Gastroenterology (931 citations), Pulmonary and Respiratory Medicine (790 citations) and Surgery (601 citations). Published in Cancer.

Countries where authors are citing Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era

Specialization
Citations

This map shows the geographic impact of Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era more than expected).

Fields of papers citing Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1002/cncr.20862.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026